Author

Paridhi Sukheja

Institution: California Institute for Biomedical Research

Observed institutions: Rutgers, The State University of New Jersey, Scripps Research Institute, California Institute for Biomedical Research, Rutgers Health, Rutgers New Jersey Medical School

ORCID: 0000-0003-3800-6654

Observed ORCID: 0000-0003-3800-6654

OpenAlex ID: A5000121754

A Novel Small-Molecule Inhibitor of the Mycobacterium tuberculosis Demethylmenaquinone Methyltransferase MenG Is Bactericidal to Both Growing and Nutritionally Deprived Persister Cells

2017 · Paridhi Sukheja, Pradeep Kumar, et al. · mBio · 87

Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA

2018 · Pradeep Kumar, Glenn C. Capodagli, et al. · mBio · 51

A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA

2020 · Daigo Inoyama, Divya Awasthi, et al. · Cell chemical biology · 42

SuFEx-based antitubercular compound irreversibly inhibits Pks13

2025 · Inna V. Krieger, Paridhi Sukheja, et al. · Nature · 34

Synthesis and structure–activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents

2023 · Baiyuan Yang, Paridhi Sukheja, et al. · Bioorganic & Medicinal Chemistry Letters · 8

Novel isoxazole thiophene-containing compounds active against Mycobacterium tuberculosis

2025 · Gabrielle Martinez, Kirsten Tolentino, et al. · Bioorganic & Medicinal Chemistry Letters · 7

Evolution of Small Molecule Inhibitors of Mycobacterium tuberculosis Menaquinone Biosynthesis

2025 · Pankaj Sharma, Quan Jiang, et al. · Journal of Medicinal Chemistry · 3

Inhibition of de novo fatty acid synthesis in Mycobacterium tuberculosis

2025 · Emma K. Roszkowski, Sarita Charap, et al. · Journal of Biological Chemistry · 2

Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation

2026 · Dirk Schnappinger, Steven J Berthel, et al. · EMBO Molecular Medicine · 1

Design, Synthesis, and Biological Evaluation of Tetrazol-2-yl-acetamides as Novel Antitubercular Agents

2025 · Baiyuan Yang, Paridhi Sukheja, et al. · ACS Medicinal Chemistry Letters · 1

Development of amidase-dependent pyrazinoic acid prodrugs with activity against pyrazinamide resistant Mycobacterium tuberculosis

2022 · Carly Levine, Ravindra Jadhav, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

Discovery and Structure–Activity Relationship Optimization of a Novel Rv1625c Agonist Chemotype with Antitubercular Activity

2026 · Han Xie, Paridhi Sukheja, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Works count: 12

Citation count: 237

H-index: 6

I10-index: 4